Potrero Hill Advisors

Strategic and Financial Advisory Services for the Life Sciences


Potrero Hill Advisors provides strategic CFO and operational financial support to growing life sciences companies. Our seasoned team brings a broad range of skills to efficiently assess your needs and deliver top quality service so that you can focus on other priorities. We assist the CEO and executive team in financing strategy and fundraising. We provide sound execution in accounting operations, audit management and preparation for significant transitions from early growth through initial public offerings.


Investor IPO and fundraising activities

investor activities


Investor Targeting

Investor Meeting Preparation

IPO Planning and Preparation

Financial planning and modeling


 Strategic Planning

Financial Planning

Infrastructure Planning


Operations Accounting Management


 Operations and Accounting Support

Financial Reporting

Accounting Policies and Controls

How We Work


Our team is comprised of seasoned professionals including  CFOs,  controllers, finance directors, accountants, and managers. Individually we bring subject matter expertise and specialization; as a team we  provide our clients with the comprehensive skill set necessary to establish a solid financial foundation and fuel growth.

We design systems and processes using a strategic approach that enables seamless handoff to your emerging in-house team at the optimal time. We also cultivate and maintain relationships with industry investors, CEOs, and other key decision makers.



Client Comments


"When our CFO departed, Sharon immediately stepped into the role, and in less than a month executed a financing. She kept the SEC reporting and Audit Committee trains running on time and identified and mentored our permanent CFO. She created a perfect, seamless transition." 
- Linda Grais, CEO Ocera (OCRX)


"Over the past two years, Sharon and her people supported Allakos’ growth from a nearly virtual preclinical company into a clinical stage biotech company with two products in multiple clinical trials. She has taken us through three annual audits including a successful changeover to a big four audit firm. I particularly value Sharon’s counsel and connections as we continue to execute our financing strategy."
- Allakos, Chris Bebbington, CEO


"Sharon’s connections and seasoned insights have been invaluable to us. Over the years she and her team have helped us with everything from raising funds to operations. She is a trusted advisor to our executive team."
- David Kim, 4D Molecular Therapeutics


"Sharon helped bring clarity to our strategic plan at pivotal time for our company. At the same time, her internal leadership and deep bench of outside resources helped equip our new CFO to execute a smooth IPO process."
- Sean McCarthy, CEO Cytomx Therapeutics, Inc. (CTMX)